Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19

BACKGROUND: Whether angiotensin-converting enzyme (ACE) Inhibitors and angiotensin receptor blockers (ARBs) mitigate or exacerbate SARS-CoV-2 infection remains uncertain. In a national study, we evaluated the association of ACE inhibitors and ARB with coronavirus disease-19 (COVID-19) hospitalizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Khera, Rohan, Clark, Callahan, Lu, Yuan, Guo, Yinglong, Ren, Sheng, Truax, Brandon, Spatz, Erica S, Murugiah, Karthik, Lin, Zhenqiu, Omer, Saad B, Vojta, Deneen, Krumholz, Harlan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273249/
https://www.ncbi.nlm.nih.gov/pubmed/32511481
http://dx.doi.org/10.1101/2020.05.17.20104943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273249/
https://www.ncbi.nlm.nih.gov/pubmed/32511481
http://dx.doi.org/10.1101/2020.05.17.20104943

Ejemplares similares